Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-04-12

FDA Approved: BUPROPION HYDROCHLORIDE (XL) — Original Application (ScieGen Pharmaceuticals,Inc.)

View source ↗

Summary

FDA approved ScieGen Pharmaceuticals' generic bupropion hydrochloride extended-release (XL) for the same indications as the reference product, confirming therap…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BUPROPION HYDROCHLORIDE XL (BUPROPION HYDROCHLORIDE)

Snippet

ORIG AP for BUPROPION HYDROCHLORIDE (XL) (BUPROPION HYDROCHLORIDE)